AU Patent

AU2017324855A1 — Formulations of ( R)-2-amino-3-phenylpropyl carbamate

Assigned to Jazz Pharmaceuticals Ireland Ltd · Expires 2019-03-28 · 7y expired

What this patent protects

The present invention relates to immediate release formulations of

USPTO Abstract

The present invention relates to immediate release formulations of

Drugs covered by this patent

solriamfetol-hydrochloride (SOLRIAMFETOL HYDROCHLORIDE)

Patent Metadata

Patent number: AU2017324855A1
Jurisdiction: AU
Classification: —
Expires: 2019-03-28
Drug substance claim: No
Drug product claim: No
Assignee: Jazz Pharmaceuticals Ireland Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.